|
|
Article: Other News To Note.
- Article from:
- BIOWORLD Today
- Article date:
- November 3, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
o Allergan Inc., of Irvine, Calif., gained approval to market Alphagan P 0.1 percent for lowering intraocular pressure in patients with open-angle glaucoma or ocular hypertension. The product is an optimized formulation of Alphagan 0.2 percent and was developed to minimize drug exposure while maintaining the drug's favorable efficacy profile.
o Antibe Therapeutics Inc., of Calgary, Alberta, appointed Daniel Legault president and CEO and Alain Wilson chief financial officer. Legault is a founding principal of Revelstoke Partners. Prior to that, he was president of Opal Sky. Wilson also is a founding partner of Revelstoke Partners. He previously was the office head ...